These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25151667)

  • 1. When very high cholesterol runs in the family. More than 600,000 Americans have an inherited condition that can cause heart attacks at an early age.
    Harv Heart Lett; 2014 May; 24(9):4. PubMed ID: 25151667
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
    Saito Y; Shinomiya M; Shirai K; Yoshida S
    Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
    [No Abstract]   [Full Text] [Related]  

  • 3. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes.
    Alonso R; Mata P; Zambón D; Mata N; Fuentes-Jiménez F
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):327-42. PubMed ID: 23469913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolaemia and coronary artery disease: A silent killer with several faces.
    Ferrières J
    Arch Cardiovasc Dis; 2019 Feb; 112(2):75-78. PubMed ID: 30606472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholesterol and coronary sclerosis].
    Immich H
    Versicherungsmedizin; 1997 Jun; 49(3):86-8. PubMed ID: 9273772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluvastatin].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():587-91. PubMed ID: 11347136
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 9. Atorvastatin treatment improves myocardial and peripheral blood flow in familial hypercholesterolemia subjects without evidence of coronary atherosclerosis.
    Lario FC; Miname MH; Tsutsui JM; Santos RD; Kowatsch I; Sbano JC; Ramires JA; Kalil Filho R; Mathias W
    Echocardiography; 2013 Jan; 30(1):64-71. PubMed ID: 22957727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary prevention in patients with a coronary disorder: wider indication for cholesterol-lowering drugs].
    Peters RJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(12):604-6. PubMed ID: 7700402
    [No Abstract]   [Full Text] [Related]  

  • 11. The need for a different cholesterol lowering drug.
    Steiner G
    Can J Clin Pharmacol; 2003; 10 Suppl A():4A-6A. PubMed ID: 14571300
    [No Abstract]   [Full Text] [Related]  

  • 12. Focus on HDL as a therapeutic target for CAD risk reduction.
    Davidson MH
    Am J Cardiol; 2009 Nov; 104(10 Suppl):1E-2E. PubMed ID: 19895937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of coronary heart disease in familial hypercholesterolemia].
    Miserez AR; Keller U
    Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum plant sterols and atherosclerosis: is there a place for statin-ezetimibe combination?
    Radermecker RP; Scheen AJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1496-7; author reply 1497-8. PubMed ID: 16580546
    [No Abstract]   [Full Text] [Related]  

  • 16. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
    Circulation; 1994 Mar; 89(3):1333-445. PubMed ID: 8124825
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials and tribulations. Cholesterol veers off script.
    Couzin J
    Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
    [No Abstract]   [Full Text] [Related]  

  • 18. The case for medical treatment in chronic stable coronary artery disease.
    Nash DT
    Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414
    [No Abstract]   [Full Text] [Related]  

  • 19. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.